Publications by authors named "Anne G Loft"

Claim this Profile
D
Defining Bath Ankylosing Spondylitis Disease Activity Index Cut-off Values for Disease Activity States in a Multinational European Cohort of Patients With Axial Spondyloarthritis.
Stylianos Georgiadis, Lykke Midtbøll Ørnbjerg, Brigitte Michelsen, Tore K Kvien, Mehrdad Shoae Kazemi, Anne Gitte Loft

ACR Open Rheumatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing internal construct validity of DAPSA and DAPSA28 in psoriatic arthritis: a European observational study using confirmatory factor analysis and additional psychometric testing.
Jacob Brauner Jørgensen, Karl Bang Christensen, Brigitte Michelsen, Anne Gitte Loft, Simon Horskjær Rasmussen

RMD Open· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety outcomes in 2132 Danish patients with inflammatory arthritis treated with biosimilar infliximab (GP1111) in routine care.
Hafsah Nabi, Kasper Yde Jensen, Rasmus Westermann, Oliver Hendricks, Dorte Vendelbo Jensen, Anne Gitte Loft

Ther Adv Musculoskelet Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complement system activation is associated with spinal radiographic progression in axial spondyloarthritis after 2 years of follow-up: findings from the CONSUL RCT.
Clara Mistegaard, Anne Troldborg, Murat Torgutalp, Anne Gitte Loft, Steffen Thiel

RMD Open· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advanced Combination Therapy with Tofacitinib and Biologic Agents for Psoriasis and Psoriatic Arthritis: A Case Series.
Cathrine Dawn Büttner Elgaard, Trine Bay Laurberg, Jørgen Agnholt, Anne Gitte Loft, Kasper Fjellhaugen Hjuler

Case Rep Dermatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring associations of single nucleotide polymorphisms in ERAP1 and ERAP2 with susceptibility to multiple immune-mediated inflammatory diseases.
Sofie Jørgensen, Trine Bertelsen, Lasse Kronborg, Anders Dige, Trine Bay Laurberg, Anne Gitte Loft

Hum Immunol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interchangeability of patient pain, fatigue and global scores in patients with spondyloarthritis - a registry-based simulation study.
Stylianos Georgiadis, Daniela Di Giuseppe, Almut Scherer, Merete Lund Hetland, Gareth T Jones, Anne Gitte Loft

BMC Rheumatol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of Secukinumab Treatment Response and Continuation in Axial Spondyloarthritis: Results From the EuroSpA Research Collaboration Network.
Marion Pons, Stylianos Georgiadis, Merete Lund Hetland, Zohra Faizy Ahmadzay, Simon Rasmussen, Anne G Loft

J Rheumatol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disparities in the organisation of national healthcare systems for treatment of patients with psoriatic arthritis and axial spondyloarthritis across Europe.
Brigitte Michelsen, Mikkel Østergaard, Michael John Nissen, Adrian Ciurea, Burkhard Möller, Anne Gitte Loft

Health Policy· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Four-year secukinumab treatment outcomes in European real-world patients with axial spondyloarthritis and psoriatic arthritis.
Marion Pons, Stylianos Georgiadis, Mikkel Østergaard, Zohra Faizy Ahmadzay, Bente Glintborg, Anne Gitte Loft

Joint Bone Spine· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex differences in patient-reported outcome measures and the association with clinical factors in axial spondyloarthritis patients treated with tumour necrosis factor inhibitors.
Pasoon Hellamand, Marleen G H van de Sande, Michael T Nurmohamed, Ronald F van Vollenhoven, Rosemary J Hollick, Anne G Loft

Rheumatology (Oxford)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenge of missing data in observational studies: investigating cross-sectional imputation methods for assessing disease activity in axial spondyloarthritis.
Stylianos Georgiadis, Marion Pons, Simon Rasmussen, Merete Lund Hetland, Louise Linde, Anne G Loft

RMD Open· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Handling of missing component information for common composite score outcomes used in axial spondyloarthritis research when complete-case analysis is unbiased.
Christos Polysopoulos, Stylianos Georgiadis, Lykke Midtbøll Ørnbjerg, Almut Scherer, Daniela Di Giuseppe, Anne Gitte Loft

BMC Med Res Methodol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in the response to TNF inhibitors at distinct joint locations in patients with psoriatic arthritis: results from nine European registries.
Adrian Ciurea, Seraphina Kissling, Andrea Götschi, Lykke Midtbøll Ørnbjerg, Simon Horskjær Rasmussen, Anne Gitte Loft

Arthritis Res Ther· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complement proteins in axial spondyloarthritis: associations with disease activity and TNFi treatment response in a multicentre RCT.
Clara Mistegaard, Anne Troldborg, Murat Torgutalp, Anne Gitte Loft, Steffen Thiel

Rheumatol Adv Pract· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing DAPSA, DAPSA28, and DAS28-CRP in Patients With Psoriatic Arthritis Initiating a First Tumor Necrosis Factor Inhibitor Across Nine European Countries.
Louise Linde, Stylianos Georgiadis, Lykke M Ørnbjerg, Simon H Rasmussen, Brigitte Michelsen, Anne Gitte Loft

Arthritis Care Res (Hoboken)· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of patient characteristics on ASDAS disease activity state cut-offs in axial spondyloarthritis: results from nine European rheumatology registries.
Lykke M Ørnbjerg, Stylianos Georgiadis, Tore K Kvien, Brigitte Michelsen, Simon Rasmussen, Anne Gitte Loft

RMD Open· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recording of non-musculoskeletal manifestations, comorbidities and safety outcomes in European spondyloarthritis registries: a survey.
Zohra F Ahmadzay, Jette Heberg, Jacob B Jørgensen, Lykke M Ørnbjerg, Mikkel Østergaard, Anne Gitte Loft

Rheumatol Adv Pract· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring TNFi drug-levels and anti-drug antibodies during tapering among patients with inflammatory arthritis: secondary analyses from the randomised BIODOPT trial.
Line Uhrenholt, Mads E R Sørensen, Karen B Lauridsen, Kirsten Duch, Lene Dreyer, Anne Gitte Loft

Rheumatol Int· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug effectiveness of 2nd and 3rd TNF inhibitors in psoriatic arthritis - relationship with the reason for withdrawal from the previous treatment.
Lykke Midtbøll Ørnbjerg, Cecilie Heegaard Brahe, Louise Linde, Lennart Jacobsson, Michael J Nissen, Anne Gitte Loft

Joint Bone Spine· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of secukinumab in radiographic and non-radiographic axial spondyloarthritis: a European routine-care observational study.
Sara Nysom Christiansen, Simon Horskjær Rasmussen, Mikkel Ostergaard, Marion Pons, Brigitte Michelsen, Anne Gitte Loft

RMD Open· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring complement biomarkers in suspected axial spondyloarthritis.
Clara Elbæk Mistegård, Anne Troldborg, Anne Gitte Loft, Steffen Thiel, Laura Spiller

RMD Open· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-Reported Outcomes (PROs) and PRO Remission Rates in 12,262 Biologic-Naïve Patients With Psoriatic Arthritis Treated With Tumor Necrosis Factor Inhibitors in Routine Care.
Lykke M Ørnbjerg, Kathrine Rugbjerg, Stylianos Georgiadis, Simon H Rasmussen, Lennart Jacobsson, Anne G Loft

J Rheumatol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported outcomes in axial spondyloarthritis and psoriatic arthritis patients treated with secukinumab for 24 months in daily clinical practice.
Sara Nysom Christiansen, Simon Horskjær Rasmussen, Marion Pons, Brigitte Michelsen, Bente Glintborg, Anne Gitte Loft

Semin Arthritis Rheum· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of patient endotypes and adalimumab treatment responders in axial spondyloarthritis using blood-derived extracellular matrix biomarkers.
Helena Port, Frederik Christiansen, Signe Holm Nielsen, Peder Frederiksen, Anne-C Bay-Jensen, Anne Gitte Loft

RMD Open· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis